| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Health Care Technology (Health Care sector), OMCL's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 385.5K | $14.19M | - | |
| Other | 117.8K | $4.34M | - | |
| VP | 91.7K | $3.37M | - | |
| COO | 87.2K | $3.21M | - | |
| CFO | 32.9K | $1.21M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2018 | Kuipers Peter J.70 | Executive V P&CFO | Sell | 1,044 | $44.34 | $46,288.87 | -1.8% | |
| Mar 6, 2018 | Lipps Randall A53 | Chairman, President And CEO | Sell | 8,186 | $44.21 | $361,938.26 | -3.7% | |
| Dec 18, 2017 | Kuipers Peter J.70 | Executive V.p. CFO | Sell | 1,926 | $51.69 | $99,559.37 | -5.0% | |
| Nov 17, 2017 | Kuipers Peter J.70 | Executive V.p. CFO | Sale+OE | 4,724 | $47.74 | $225,536.60 | -5.8% | |
| Nov 17, 2017 | Johnston Dan S70 | Evp-chief Legal &Admin Off | Sale+OE | 14,613 | $47.81 | $698,626.13 | -18.1% | |
| Nov 7, 2017 | Drew J Christopher | Exe VP, Sales &Marketing | Sale+OE | 29,750 | $47.77 | $1,421,114.83 | -11.6% | |
| Nov 6, 2017 | Taborga Jorge R. | Executive Vp. Engineering | Sell | 6,295 | $48.69 | $306,484.67 | -12.6% | |
| Oct 2, 2017 | Kuipers Peter J.70 | Executive V.p. CFO | Sale+OE | 3,532 | $50.96 | $179,997.80 | -2.9% | |
| Sep 15, 2017 | Seim Robin Gene | EVP, Global A &M Adherence | Sale+OE | 9,780 | $48.97 | $478,965.72 | -17.5% | |
| Sep 5, 2017 | Petersmeyer Gary S59 | Director | Sell | 1,000 | $51.73 | $51,734.00 | -5.5% |